• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP; ALPHA-FETOPROTEIN Back to Search Results
Catalog Number 03P36-30
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/28/2015
Event Type  malfunction  
Event Description
The customer reports a falsely elevated architect afp assay result of 80.27 ng/ml generated on an architect i2000sr analyzer (serial number (b)(3)) in their laboratory.The sample was then tested on another architect i2000sr analyzer in their laboratory, which generated a result of 2.77 ng/ml that the customer believes to be correct.The customer states that this is an intermittent issue and is not related to any specific lot of reagent.No suspect results were reported from the lab with no patient impact.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(4).
 
Manufacturer Narrative
No returns were made available from the customer site for this evaluation.Accuracy testing was performed using a retained kit of architect afp assay lot 46114lf00 across three architect isystems by running 16 replicates each of an afp low panel sample on each analyzer.All results met specifications indicating acceptable product performance.A review of data from the customer site along with instrument logs downloaded from the analyzer found no unusual performance issues.A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation.The architect afp assay package insert and the architect operation manual both contain information to address the current customer issue.Based on the available information from the customer site and from the results of this evaluation, there is no evidence to reasonably suggest a product malfunction occurred.The issue was addressed through standard troubleshooting procedures.Catalog#, corrected from 03p36-20 to 03p36-30.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Type of Device
ALPHA-FETOPROTEIN
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
Manufacturer (Section G)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI   NA
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key4712423
MDR Text Key5649359
Report Number3008344661-2015-00010
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
P120008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/01/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/21/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/21/2015
Device Catalogue Number03P36-30
Device Lot Number46114LF00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/15/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/12/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER LN:03M74-02; SN: (B)(4); ARCHITECT I2000SR ANALYZER LN:03M74-02; SN: (B)(4)
-
-